Ariel Eber is a Dermatology physician affiliated with University of Miami. OpenAlex indexes 69 publications with 794 citations (h-index 14); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1611 NW 12th Ave
Miami, FL 331361005
Telephone
305-401-0066Provider last certified this registry record 16 Nov 2023.
Clinical trials
- Aviclear for Hidradenitis Suppurativa (HS)
Sponsor: University of Miami
- Rosacea Radiofrequency Microneedling
Sponsor: University of Miami
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Galderma Laboratories, L.P.Program year202512 payments
- Incyte CorporationProgram year20254 payments
- Musculoskeletal Transplant Foundation Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
51.4%Azole Antifungal41.2%Ketoconazole100%Part D≥25 patientsTetracycline-class Drug10.1%Doxycycline Hyclate100%Part D≥11 patientsDermatology
31.8%Corticosteroid23%Triamcinolone Acetonide100%Part D≥23 patientsInterleukin-4 Receptor alpha Antagonist8.8%Dupixent Pen100%Part D<11 patientsSensory organs
16.9%Corticosteroid16.9%Clobetasol Propionate100%Part D≥13 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Exosomes: A Comprehensive Review for the Practicing Dermatologist.
PubMed
2025 - Response to Peng et al’s “Efficacy and safety of 308-nanometer light-emitting diode phototherapy for prurigo nodularis: A randomized and self-controlled clinical trial”
Journal of the American Academy of Dermatology
2025 - Low-Level Laser and LED Therapy in Alopecia: A Systematic Review and Meta-Analysis
Dermatologic Surgery
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Myerburg, MD
University of Miami
Thomas Hooton, MD
University of Miami
Harry Flynn, MD
University of Miami
Alan Wein, MD
University of Miami
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”